ELVN - Enliven Therapeutics, Inc.
NEXT EARNINGS:
Mar 12, 2026
(in 15 days)
EPS Est: $-0.42
|
Rev Est: $8330
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$43.33
DETAILS
HIGH:
$52.00
LOW:
$39.00
MEDIAN:
$39.00
CONSENSUS:
$43.33
UPSIDE:
53.00%
Market Cap:
1.68B
Volume:
775,280
Avg Volume:
1,019,542
52 Week Range:
13.3-30.22
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.14
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
62
IPO Date:
2020-03-12
EPS (TTM):
-1.89
P/E Ratio:
-11.90
Revenue (TTM):
N/A
Total Assets:
325.76M
Total Debt:
N/A
Cash & Equiv:
124.12M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-33.7%
Debt/Equity:
N/A
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-12 | $-0.32 | $-0.43 | +25.6% | — | $8330 | — |
| 2025-08-13 | $-0.49 | $-0.53 | +7.5% | — | — | — |
| 2025-05-14 | $-0.57 | $-0.51 | -11.8% | — | — | — |
| 2025-03-13 | $-0.46 | $-0.53 | +13.2% | — | — | — |
| 2024-11-13 | $-0.48 | $-0.52 | +7.7% | — | — | — |
| 2024-08-13 | $-0.41 | $-0.58 | +29.3% | — | — | — |
| 2024-05-14 | $-0.54 | $-0.58 | +6.9% | — | — | — |
| 2024-03-14 | $-0.47 | $-0.56 | +16.1% | $440000 | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (89.02M) | (71.58M) | (37.66M) | (24.74M) | (18.97M) | (23.46M) | (11.34M) | 0 |
| EPS | -1.89 | -2.01 | -6.03 | -3.17 | -4.31 | -5.43 | -2.62 | 0.00 |
| Total Assets | 325.76M | 271.87M | 83.30M | 113.33M | 90.84M | 33.30M | 7.71M | 10.22M |
| Total Debt | 0 | 335,000 | 323,000 | 159,000 | 0 | 0 | 0 | 660,000 |
| Cash & Equivalents | 124.12M | 100.14M | 75.54M | 110.02M | 47.70M | 4.94M | 7.38M | 9.67M |
| Operating Cash Flow | (73.19M) | (61.27M) | (32.08M) | (19.13M) | (8.53M) | (21.88M) | (8.78M) | (8.79M) |
| Free Cash Flow | (73.24M) | (61.42M) | (32.69M) | (19.32M) | (8.99M) | (22.02M) | (8.78M) | (8.79M) |
| FCF per Share | -1.56 | -1.73 | -5.23 | -2.47 | -2.05 | -5.10 | -2.03 | -2.03 |
| Book Value | 309.85M | 245.91M | (76.83M) | 106.86M | 84.44M | (48.85M) | (26.32M) | (15.53M) |
| Cash & ST Investments | 313.44M | 253.15M | 75.54M | 110.02M | 88.22M | 28.91M | 7.38M | 9.67M |
| ROC Equity | -0.29 | -0.29 | N/A | -0.23 | -0.22 | N/A | N/A | N/A |